Cancer is a leading killer of pets today. Yet, while over 200 drugs are currently approved to treat human cancers, there are only a handful of FDA-approved veterinary drugs for canine cancer, and none for cats.
We believe veterinarians, companion animals, and their families deserve greater access to novel, advanced cancer & dog lymphoma treatments. This inspires our team of veterinary oncologists and researchers to select promising innovations in human medicine, and develop them specifically for the treatment of cancer in pets.
Our rigorous application of evidence-based medicine drives us to develop breakthrough therapies that provide veterinarians and pet owners with new tools and options to enhance and extend quality of life for animal companions living with cancer.
TANOVEA® (rabacfosadine for injection) is a breakthrough canine lymphoma treatment developed by VetDC, and is now available through Elanco Animal Health.